These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22743090)
21. Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system. Szot P Epilepsia; 2012 Jun; 53 Suppl 1():61-6. PubMed ID: 22612810 [TBL] [Abstract][Full Text] [Related]
22. [Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease]. Rami L; Valls-Pedret C; Bartrés-Faz D; Caprile C; Solé-Padullés C; Castellvi M; Olives J; Bosch B; Molinuevo JL Rev Neurol; 2011 Feb; 52(4):195-201. PubMed ID: 21312165 [TBL] [Abstract][Full Text] [Related]
23. Cognitive function and frontal lobe atrophy in normal elderly adults: Implications for dementia not as aging-related disorders and the reserve hypothesis. Meguro K; Shimada M; Yamaguchi S; Ishizaki J; Ishii H; Shimada Y; Sato M; Yamadori A; Sekita Y Psychiatry Clin Neurosci; 2001 Dec; 55(6):565-72. PubMed ID: 11737788 [TBL] [Abstract][Full Text] [Related]
25. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease. Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283 [TBL] [Abstract][Full Text] [Related]
26. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease. Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584 [TBL] [Abstract][Full Text] [Related]
27. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? Sierksma AS; van den Hove DL; Steinbusch HW; Prickaerts J Eur J Pharmacol; 2010 Jan; 626(1):72-82. PubMed ID: 19837053 [TBL] [Abstract][Full Text] [Related]
28. Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. Belleville S; Clément F; Mellah S; Gilbert B; Fontaine F; Gauthier S Brain; 2011 Jun; 134(Pt 6):1623-34. PubMed ID: 21427462 [TBL] [Abstract][Full Text] [Related]
29. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Costa DA; Cracchiolo JR; Bachstetter AD; Hughes TF; Bales KR; Paul SM; Mervis RF; Arendash GW; Potter H Neurobiol Aging; 2007 Jun; 28(6):831-44. PubMed ID: 16730391 [TBL] [Abstract][Full Text] [Related]
30. On the trail of a cognitive enhancer for the treatment of schizophrenia. Stip E; Chouinard S; Boulay LJ Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228 [TBL] [Abstract][Full Text] [Related]
32. Brain aging and Alzheimer's disease; use it or lose it. Swaab DF; Dubelaar EJ; Hofman MA; Scherder EJ; van Someren EJ; Verwer RW Prog Brain Res; 2002; 138():343-73. PubMed ID: 12432778 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Riley KP; Snowdon DA; Markesbery WR Ann Neurol; 2002 May; 51(5):567-77. PubMed ID: 12112102 [TBL] [Abstract][Full Text] [Related]
34. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels. Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506 [TBL] [Abstract][Full Text] [Related]
35. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease. Geldenhuys WJ; Van der Schyf CJ Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055 [TBL] [Abstract][Full Text] [Related]
36. Sex differences in Alzheimer's disease. Laws KR; Irvine K; Gale TM Curr Opin Psychiatry; 2018 Mar; 31(2):133-139. PubMed ID: 29324460 [TBL] [Abstract][Full Text] [Related]
37. The challenges of cognitive aging: integrating approaches from science to intergenerational relationships. Whitehouse P J Alzheimers Dis; 2013; 36(2):225-32. PubMed ID: 23619307 [TBL] [Abstract][Full Text] [Related]
39. Cognitive Impairment in Alzheimer's and Metabolic Diseases: A Catecholaminergic Hypothesis. Guzmán-Ramos K; Osorio-Gómez D; Bermúdez-Rattoni F Neuroscience; 2022 Aug; 497():308-323. PubMed ID: 35654292 [TBL] [Abstract][Full Text] [Related]
40. Sex and gender differences in cognitive and brain reserve: Implications for Alzheimer's disease in women. Subramaniapillai S; Almey A; Natasha Rajah M; Einstein G Front Neuroendocrinol; 2021 Jan; 60():100879. PubMed ID: 33137359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]